Latest ESRD Stories

- U.S. FDA approves Investigational New Drug Application to begin U.S. clinical trials RESEARCH TRIANGLE PARK, N.C., April 24, 2013 /PRNewswire/ -- Humacyte, Inc., today announced the accomplishment of significant milestones in the clinical development of its innovative bioengineered blood vessel technology - the first off-the-shelf, human-derived, artificial blood vessels. The company received U.S. Food and Drug Administration (FDA) approval for an Investigational New Drug...

NEW YORK, Jan. 28, 2013 /PRNewswire/ -- Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) today announced successful top-line results from the long-term Phase 3 study of Zerenex(TM) (ferric citrate), the Company's ferric iron-based phosphate binder drug candidate, for the treatment of elevated serum phosphorus levels, or hyperphosphatemia, in patients with end-stage renal disease (ESRD) on dialysis. In this study, Zerenex met the study's primary endpoint, described below,...

LAKE SUCCESS, N.Y., Jan. 18, 2013 /PRNewswire-USNewswire/ -- IPRO, one of the nation's largest healthcare quality improvement contractors, has been awarded three major federal contracts to oversee the provision of End-Stage Renal Disease (ESRD) services to Medicare beneficiaries. All three-year awards support dialysis and renal transplantation centers in maintaining high standards of care for ESRD patients. All are administered by the Centers for Medicare & Medicaid Services (CMS)...

WASHINGTON, Dec. 10, 2012 /PRNewswire-USNewswire/ -- Dialysis Patient Citizens issued the following statement in response to today's release of the Government Accountability Office (GAO) report entitled "End-Stage Renal Disease: Reduction in Drug Utilization Suggests Bundled Payment Rate is Too High": "Dialysis Patient Citizens (DPC) is extremely concerned by the GAO's findings of an apparent decline in drug utilization for dialysis patients, but urges restraint and careful...

Still Absorbing Cuts, Changes from 'Bundling' Rules, Community Urges Stability WASHINGTON, Nov. 5, 2012 /PRNewswire-USNewswire/ -- Kidney Care Partners (KCP), a broad-based coalition of patient advocates, dialysis professionals, care providers and manufacturers working together to improve quality of care for individuals with Chronic Kidney Disease (CKD) and End-Stage Renal Disease (ESRD), commended the Administration for the latest round of federal regulations implementing the...

Being overweight and obese during adolescence appears related to an increased risk of all-cause treated end-stage renal disease (ESRD) during a 25-year period, according to a report published Online First by Archives of Internal Medicine, a JAMA Network publication. Children and adolescents with high body mass index (BMI) often become obese adults, and obese adults are at risk for chronic conditions such as diabetes, which can mean future risk of chronic kidney disease and ESRD, according...

LAWRENCE, Mass., Sept. 6, 2012 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that it submitted public comments to the Centers for Medicare and Medicaid Services (CMS) regarding its Proposed Rule for the Changes to the End-Stage Renal Disease (ESRD) Prospective Payment System for 2013. NxStage's comments call for CMS to correct the current insufficient and inequitable payments for home hemodialysis...

LAWRENCE, Mass., Aug. 29, 2012 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that the American Association of Kidney Patients (AAKP) has honored NxStage System One(TM) patient Brian Hess with the Samuel J. Orenstein Award. The award is presented each year to the AAKP member who consistently provides extraordinary service in helping the organization achieve its goals to educate and improve the health...

ORLANDO, Fla., Aug. 7, 2012 /PRNewswire/ -- Information Architects Corporation (OTCQB: IACH) announced today on Monday, August 6th, the company signed a contract to acquire The Miami Prevention & Kidney Center LLC. (MPKC). Founded in 2008, the centers will provide lifesaving hemodialysis to individuals diagnosed with End Stage Renal Disease (ESRD). The initial center is scheduled to begin providing dialysis services for patients in the South Florida area beginning by the end of...

WASHINGTON, March 13, 2012 /PRNewswire-USNewswire/ -- Dialysis Patient Citizens (DPC), the nation's largest patient-led organization representing dialysis patients, applauded the Administration for taking steps to solidify a key provision that will ensure end stage renal disease (ESRD) patients have equal access to private coverage as Affordable Care Act reforms are implemented. In a rule released yesterday by the Department of Health and Human Services, the Administration clarified...